3M awarded $34.2M from U.S. Army Medical Research Acquisition Activity

3M Health Care’s Medical Solutions Division was awarded $34.2M from the U.S. Army Medical Research Acquisition Activity to develop a range of new solutions for infection prevention, wound management and wound healing. 3M will lead a program focused on treatment strategies that can be used in austere settings, especially those related to mass casualty and delayed evacuation situations. In addition, the program will work to assess biofilm control, biomarker monitoring and healing in acute trauma situations such as blasts, burns, and gunshot wounds that occur in civilian and military settings. 3M will collaborate with the University of Minnesota Medical School, the 59th Medical Wing Science & Technology Office of the Chief Scientist, Naval Medical Research Unit-San Antonio and The University of Texas Health Science Center at San Antonio in this program. The awarded funding will support four separate product solutions, with studies that range from prototype and formulation development to completion of two clinical studies to be used for product registration.